PD-L1、PD-L2和JAK2同时扩增在转移性肺腺癌中作为免疫检查点抑制剂反应的生物标志物的作用:一份病例报告

{"title":"PD-L1、PD-L2和JAK2同时扩增在转移性肺腺癌中作为免疫检查点抑制剂反应的生物标志物的作用:一份病例报告","authors":"W. Phillips, A. Awan, B. Lo, A. Redway, G. Nicholas","doi":"10.21037/pcm-22-39","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":74487,"journal":{"name":"Precision cancer medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The role of concurrent amplification of PD-L1, PD-L2 and JAK2 in metastatic lung adenocarcinoma as a biomarker of immune checkpoint inhibitor response: a case report\",\"authors\":\"W. Phillips, A. Awan, B. Lo, A. Redway, G. Nicholas\",\"doi\":\"10.21037/pcm-22-39\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":74487,\"journal\":{\"name\":\"Precision cancer medicine\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Precision cancer medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21037/pcm-22-39\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Precision cancer medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21037/pcm-22-39","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}